Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Small Pharma (TSE:DMT)
TSXV:DMT
Small Pharma (DMT) Stock Price & Analysis
8 Followers
DMT Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.06 - C$0.22
Previous CloseC$0.17
Volume375.75K
Average Volume (3M)325.58K
Market Cap
C$54.67M
Enterprise ValueN/A
Total Cash (Recent Filing)C$13.15M
Total Debt (Recent Filing)C$548.26K
Price to Earnings (P/E)-2.4
Beta-0.61
Next Earnings
Oct 30, 2023EPS Estimate
-C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding321,562,487
10 Day Avg. Volume669,585
30 Day Avg. Volume325,585
Standard Deviation0.45
R-Squared0.02
Alpha-0.00030
Financial Highlights & Ratios
Price to Book (P/B)3.48
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Small Pharma News
Press ReleasesSmall Pharma Announces SPL028 R&D Strategy Update
Press ReleasesSmall Pharma Announces Management Team Change
Pre-EarningsDMT Upcoming Earnings Report: What to Expect?
DMT FAQ
What was Small Pharma’s price range in the past 12 months?
Small Pharma lowest stock price was C$0.06 and its highest was C$0.22 in the past 12 months.
What is Small Pharma’s market cap?
Currently, no data Available
When is Small Pharma’s upcoming earnings report date?
Small Pharma’s upcoming earnings report date is Oct 30, 2023 which is in 36 days.
How were Small Pharma’s earnings last quarter?
Currently, no data Available
Is Small Pharma overvalued?
According to Wall Street analysts Small Pharma’s price is currently Overvalued.
Does Small Pharma pay dividends?
Small Pharma does not currently pay dividends.
What is Small Pharma’s EPS estimate?
Small Pharma’s EPS estimate is -C$0.01.
How many shares outstanding does Small Pharma have?
Small Pharma has 321,562,500 shares outstanding.
What happened to Small Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Small Pharma?
Currently, no hedge funds are holding shares in TSE:DMT
---
Small Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.03%
12-Months-Change
Fundamentals
Return on Equity
-100.19%
Trailing 12-Months
Asset Growth
-58.29%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Small Pharma
Small Pharma Inc is a neuropharmaceutical company. It is committed towards the development of effective therapeutic treatments for mental health disorders. Small Pharma is developing N,N-dimethyltryptamine and a pipeline of novel patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders.
---
Top 5 ETFs holding DMT
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold DMT. The ETFs are listed according to market value of DMT within the ETF
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Mind Medicine
―
Revive Therapeutics
―
Numinus Wellness
―
Mydecine Innovations Group
―
---